Coherent Market Insights published a business research report on Anti-venom Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2022–2028. Anti-venom Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/1249
Overview
The process of making antivenom involves filtering blood. To separate the antivenom from other components, the blood is centrifuged. Then, the resulting plasma is purified to separate unwanted proteins. The next step of preparation involves precipitation of these unwanted proteins. Some antivenoms are further processed by adjusting the pH and adding salts to the solution. The final step in the preparation of antivenom involves using an enzyme to break down antibodies and isolate the active ingredients.
The global anti-venom market was valued at US$ 504.9 Mn in 2018, and is projected to exhibit a CAGR of 4.7% during the forecast period (2018–2026).
Global Anti-Venom Market: Drivers
Increasing cases of snake bites is expected to propel growth of the global anti-venom market over the forecast period. For instance, in Bangladesh, around 623.4 cases of snake bites are reported per 100,000 person annually, according to a study published in the Journal of Pharmacology & Clinical Toxicology, in June 2018.
Global Anti-Venom Market: Opportunities
R&D of new products is expected to offer lucrative growth opportunities for players in the global anti-venom market. For instance, in August 2021, Ophirex, Inc. in collaboration with Premier Research International LLC, initiated a placebo-controlled, phase 2 study designed to evaluate the safety, tolerability and efficacy of varespladib-methyl, concurrently with standard of care (SOC), in subjects bitten by venomous snakes.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/1249
Recent Developments
Major players operating in the global anti-venom market are focused on adopting partnership strategies to enhance their market share. For instance, in April 2018, Seqirus, a subsidiary of CSL Limited, partnered with the PNG Department of Health, the Australian High Commission, and the Charles Campbell Toxinology Centre (CCTC), at the University of PNG to provide an annual donation of 600 vials of snake and marine creature anti-venoms to PNG.
Covid-19 Impact Analysis
Globally, as of 5:50pm CET, 28 December 2021, there have been 280,119,931 confirmed cases of COVID-19, including 5,403,662 deaths, reported to WHO. As of 28 December 2021, a total of 8,687,201,202 vaccine doses have been administered. A recent study in bioRxiv* preprint server reported the virucidal and fusion-inhibiting attributes of snake venom against the COVID-19 virus.
Global Anti-Venom Market: Competitive Landscape
Major players operating in the global anti-venom market include, Bharat Serums and Vaccines Limited, BTG plc, CSL Limited, Haffkine Bio-Pharmaceutical Corporation Ltd., Incepta Pharmaceuticals Ltd., Laboratorios Silanes, Merck & Co., Inc., Pfizer, Inc., Rare Disease Therapeutics Inc., and Vins Bioproducts Limited.
Global Anti-Venom Market: Key Developments
Major players operating in the global anti-venom market are focused on approval and launch of new products to expand their product portfolio. For instance, in October 2018, Rare Disease Therapeutics, Inc. launch of ANAVIP [Crotalidae Immune F(ab’)2 (Equine)] an equine-derived antivenin indicated for the management of adult and pediatric patients with North American rattlesnake envenomation.
Buy This Report With USD 2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/1249
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Anti-venom Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Anti-venom Industry Impact
Chapter 2 Global Anti-venom Competition by Types, Applications, and Top Regions and Countries
2.1 Global Anti-venom (Volume and Value) by Type
2.3 Global Anti-venom (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Anti-venom Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Anti-venom Market Analysis
Chapter 6 East Asia Anti-venom Market Analysis
Chapter 7 Europe Anti-venom Market Analysis
Chapter 8 South Asia Anti-venom Market Analysis
Chapter 9 Southeast Asia Anti-venom Market Analysis
Chapter 10 Middle East Anti-venom Market Analysis
Chapter 11 Africa Anti-venom Market Analysis
Chapter 12 Oceania Anti-venom Market Analysis
Chapter 13 South America Anti-venom Market Analysis
Chapter 14 Company Profiles and Key Figures in Anti-venom Business
Chapter 15 Global Anti-venom Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
Continued….
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837